TumorGen

0 followers


TumorGen is developing a novel drug discovery platform to identify unseen therapeutic targets associated with cancer metastasis. Their patented technology is used to capture circulating metastatic cancer cell clusters (MCCCs).

Industries

Headquarters

Employees

Links

Org chart

Jeffrey K. Allen
Founder, President & CEO

Jeffrey K. Allen

Collapse
Peter Teriete
Scientific Co-Founder